Implications of vasomotor reactions for a combined oncotherapy including IORT. I. Angiophysiology and oncotherapy
Related Experiment Videos
M C Michailov1, E Neu, U Welscher
1Department of Biology, University of Rostock, Germany.
Frontiers of Radiation Therapy and Oncology
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Results of radiotherapy for primary vaginal cancer].
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Quantitative nanoscale vortex imaging using a cryogenic quantum magnetometer.
Nature nanotechnology·2016
Cyclosporine A kinetics in brain cell cultures and its potential of crossing the blood-brain barrier.
Toxicology in vitro : an international journal published in association with BIBRA·2015
Dynamic phase microscopy reveals periodic oscillations of endoplasmic reticulum during network formation.
Biochemistry. Biokhimiia·2014
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011
A cell-type resolved proton RBE model for potential clinical application.
Medical physics·2026
Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes.
Clinical and translational radiation oncology·2026
Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study.
Clinical and translational radiation oncology·2026
Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial.
Clinical and translational radiation oncology·2026